Thursday, March 19 2026
9:40–10:25am
Industry Theater
Learn About a PrEP Injectable Option
Industry Theater 1, Room 145AB, Level 1
Description
Explore the evidence of PrEP as a highly effective but underutilized HIV prevention strategy, including opportunities to further decrease HIV diagnoses, especially in underserved populations. Select details on clinical trial data for an injectable PrEP option and information about its use in clinical practice will also be examined.
Sponsored by
- Gilead Sciences, Inc.